Fexinidazole and Belumosudil: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 15, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Fexinidazole
No brand names on recordBelumosudil
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Let's talk about taking fexinidazole and belumosudil (Rezurock) together. Fexinidazole can slow down a liver enzyme (called CYP3A4) that your body uses to break down belumosudil. When that enzyme is slowed, belumosudil can build up higher than intended, which may raise your chance of side effects.
I want to be honest with you: this concern is based on how these drugs are expected to behave, not on hard studies in people. Still, it is worth taking seriously. The good news is your care team can manage this by keeping a closer eye on you or adjusting things as needed. Please don't stop or change either medicine on your own. Just check in with your pharmacist or doctor.
Effect: Fexinidazole is reported to inhibit CYP3A4, which can reduce metabolism of belumosudil (a CYP3A4 substrate), increasing its exposure (AUC/Cmax) and the risk of concentration-dependent adverse effects.
- Direction: Increased belumosudil exposure (enzyme inhibition; belumosudil is an active drug, not a prodrug, so effect is enhanced).
- Severity: Major.
- Onset: Unspecified.
- Evidence: Theoretical.
- Management: Avoid concomitant use where possible. If co-administered, dosing should be individualized and patients monitored more closely for belumosudil-related adverse effects.
What happens
An increased CYP3A4 substrate exposure
Interaction Deep Dive
Do not administer fexinidazole, which inhibits CYP3A4, together with substrates of CYP3A4, since elevated levels of these substrate drugs raise the likelihood of adverse reactions1.
Why it happens (mechanism)
Inhibition of CYP3A4-mediated metabolism by fexinidazole
How to manage this interaction
Here is how a care team typically handles this pairing:
- Avoidance is preferred. The documented guidance is to avoid using fexinidazole with a CYP3A4 substrate like belumosudil when possible, since levels of belumosudil could rise.
- If both are needed, your team may monitor you more closely for side effects, and your belumosudil dose may need to be adjusted and individualized by your care team.
What you should do: Keep taking both exactly as prescribed and do not make changes on your own. Tell your pharmacist or prescriber you are on both drugs, and report any new or worsening side effects.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Fexinidazole and Belumosudil together?
Fexinidazole may raise belumosudil levels by blocking its breakdown, so this combination is best avoided; if you take both, your care team can manage it with closer monitoring and dose tailoring. Talk with your pharmacist or doctor before making any changes. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Fexinidazole and Belumosudil interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Fexinidazole and Belumosudil interaction managed?
Here is how a care team typically handles this pairing: Avoidance is preferred. The documented guidance is to avoid using fexinidazole with a CYP3A4 substrate like belumosudil when possible, since levels of belumosudil could rise. If both are needed, your team may monitor you more closely for side effects, and your belumosudil dose may need to be adjusted and individualized by your care team. What… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Fexinidazole or Belumosudil need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: Fexinidazole oral tablets, fexinidazole oral tablets. sanofi-aventis US LLC (per FDA), Bridgewater, NJ, 2021. DailyMed
Keep reading about Fexinidazole
Keep reading about Belumosudil
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist